Vitality Watch

Dossier pubmed preclinical 11-nov-2026
Animal model, organoid, or cell-culture result — not yet human

A genetically encoded system to purify senescent cells.

Key claim: Researchers developed SenLect, a genetically encoded puromycin-selection system that purifies senescent cells in culture to enable high-fidelity proteomic, metabolic, and secretomic analysis without proliferating cell contamination.

Abstract

Cellular senescence is a state of irreversible cell-cycle arrest that prevents cancer but promotes aging and inflammation. Conflicting molecular profiles of senescence may arise from contamination by neighboring proliferating cells. Here, we developed SenLect (senescence selection), a genetically encoded system for purifying senescent cells in culture. SenLect expresses mCherry-2A-PuroR under the senescence-activated miR-146a promoter, providing senescent cells a selective advantage over proliferating cells during puromycin treatment. We validated SenLect in primary and immortal cells undergoing replicative senescence or various modes of stress-induced senescence. Selected cells were enriched for cell-cycle arrest, increased cell size, and lysosomal β-galactosidase activity. Removing proliferating cells revealed proteome rewiring during senescence induced by cyclin-dependent kinase 4/6 inhibition, improving detection of senescence-associated secretory phenotype (SASP) signatures, metabolic shifts, and organelle remodeling. SenLect provides a reliable method for isolating senescent cells for downstream applications.

Why this matters

[mechanism-plausible] SenLect addresses a measurement problem in senescence biology: proliferating cells in mixed cultures can confound attribution of proteins, metabolites, and secreted factors to senescent cells. [mechanism-plausible] Purified cultures enable more specific mechanistic profiling, but whether promoter-based selection captures senescent-cell heterogeneity without bias remains an open question; this laboratory tool does not establish that targeting the resulting signatures improves aging outcomes in humans.

Source

Link

Briefing card

A genetically encoded system to purify senescent cells.
Stage: preclinical · pubmed · 11-nov-2026

If you profile senescent cells in culture, SenLect provides a genetic selection method to reduce proliferating-cell contamination before molecular analysis.

Researchers developed SenLect, a genetically encoded puromycin-selection system that purifies senescent cells in culture to enable high-fidelity proteomic, metabolic, and secretomic analysis without proliferating cell contamination.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.crmeth.2026.101665

build build 880 · 2bcef25 · 2026-11-18